436 related articles for article (PubMed ID: 15061297)
1. Effect of fish oil on oxidative stress, lipid profile and renal function in IgA nephropathy.
Parinyasiri U; Ong-Ajyooth L; Parichatikanond P; Ong-Ajyooth S; Liammongkolkul S; Kanyog S
J Med Assoc Thai; 2004 Feb; 87(2):143-9. PubMed ID: 15061297
[TBL] [Abstract][Full Text] [Related]
2. Is body size a biomarker for optimizing dosing of omega-3 polyunsaturated fatty acids in the treatment of patients with IgA nephropathy?
Donadio JV; Bergstralh EJ; Bibus DM; Grande JP
Clin J Am Soc Nephrol; 2006 Sep; 1(5):933-9. PubMed ID: 17699310
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of omega-3 fatty acids in children and adults with IgA nephropathy is dosage- and size-dependent.
Hogg RJ; Fitzgibbons L; Atkins C; Nardelli N; Bay RC;
Clin J Am Soc Nephrol; 2006 Nov; 1(6):1167-72. PubMed ID: 17699343
[TBL] [Abstract][Full Text] [Related]
4. Treatment of IgA nephropathy with omega-3-polyunsaturated fatty acids: a prospective, double-blind, randomized study.
Pettersson EE; Rekola S; Berglund L; Sundqvist KG; Angelin B; Diczfalusy U; Björkhem I; Bergström J
Clin Nephrol; 1994 Apr; 41(4):183-90. PubMed ID: 8026109
[TBL] [Abstract][Full Text] [Related]
5. The effect of alpha-tocopherol on the oxidative stress and antioxidants in idiopathic IgA nephropathy.
Ong-ajyooth L; Ong-ajyooth S; Parichatikanond P
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S164-70. PubMed ID: 17718258
[TBL] [Abstract][Full Text] [Related]
6. Relationship of omega-3 fatty acid supplementation to plasma lipid peroxidation in predialysis patients with hypertriglyceridaemia.
Richard MJ; Sirajeddine MK; Cordonnier D; Tricot F; Foulon T; Mouneimne A; Maurizi J
Eur J Med; 1993 Jan; 2(1):15-8. PubMed ID: 8257999
[TBL] [Abstract][Full Text] [Related]
7. [Long-term administration of cyclosporine A in patients with IgA nephropathy].
Chábová V; Tesar V; Zabka J; Rychlík I; Merta M; Jirsa M; Stejskalová A; Stejskal J
Cas Lek Cesk; 1996 Dec; 135(24):803-6. PubMed ID: 9072300
[TBL] [Abstract][Full Text] [Related]
8. Short-term effects of fish oil treatment on urinary excretion of high- and low-molecular weight proteins in patients with IgA nephropathy.
Branten AJ; Klasen IS; Wetzels JF
Clin Nephrol; 2002 Oct; 58(4):267-74. PubMed ID: 12400841
[TBL] [Abstract][Full Text] [Related]
9. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
McKenney JM; Sica D
Pharmacotherapy; 2007 May; 27(5):715-28. PubMed ID: 17461707
[TBL] [Abstract][Full Text] [Related]
10. Effects of eicosapentaenoic acid supplementation on immunoglobulin A nephropathy.
Uchiyama-Tanaka Y; Mori Y
Ther Apher Dial; 2010 Jun; 14(3):303-7. PubMed ID: 20609183
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
Davidson MH; Stein EA; Bays HE; Maki KC; Doyle RT; Shalwitz RA; Ballantyne CM; Ginsberg HN;
Clin Ther; 2007 Jul; 29(7):1354-67. PubMed ID: 17825687
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of low-dose docosahexaenoic acid and eicosapentaenoic acid on the regulation of mitogenic signaling pathways in mesangial cells.
Yusufi AN; Cheng J; Thompson MA; Walker HJ; Gray CE; Warner GM; Grande JP
J Lab Clin Med; 2003 May; 141(5):318-29. PubMed ID: 12761475
[TBL] [Abstract][Full Text] [Related]
13. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study.
Saifullah A; Watkins BA; Saha C; Li Y; Moe SM; Friedman AN
Nephrol Dial Transplant; 2007 Dec; 22(12):3561-7. PubMed ID: 17623719
[TBL] [Abstract][Full Text] [Related]
14. Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study.
Li PK; Leung CB; Chow KM; Cheng YL; Fung SK; Mak SK; Tang AW; Wong TY; Yung CY; Yung JC; Yu AW; Szeto CC;
Am J Kidney Dis; 2006 May; 47(5):751-60. PubMed ID: 16632013
[TBL] [Abstract][Full Text] [Related]
15. Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio.
Burns T; Maciejewski SR; Hamilton WR; Zheng M; Mooss AN; Hilleman DE
Pharmacotherapy; 2007 May; 27(5):633-8. PubMed ID: 17461697
[TBL] [Abstract][Full Text] [Related]
16. Effect of 12-month therapy with omega-3 polyunsaturated acids on glomerular filtration response to dopamine in IgA nephropathy.
Sulikowska B; Niewegłowski T; Manitius J; Lysiak-Szydłowska W; Rutkowski B
Am J Nephrol; 2004; 24(5):474-82. PubMed ID: 15340256
[TBL] [Abstract][Full Text] [Related]
17. Effects of a fish oil supplement on blood pressure and serum lipids in patients treated for coronary artery disease.
Bairati I; Roy L; Meyer F
Can J Cardiol; 1992; 8(1):41-6. PubMed ID: 1617510
[TBL] [Abstract][Full Text] [Related]
18. Lack of renal effects of fish oil administration in patients with advanced cirrhosis and impaired glomerular filtration.
Badalamenti S; Salerno F; Salmeron JM; Lorenzano E; Rimola A; Ginés P; Jimenez W; Graziani G; Arroyo V; Rodes J; Ponticelli C
Hepatology; 1997 Feb; 25(2):313-6. PubMed ID: 9021940
[TBL] [Abstract][Full Text] [Related]
19. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
Trimarchi H; Muryan A; Young P; Forrester M; Iotti A; Pereyra H; Lombi F; Seminario O; Alonso M; Iotti R
Medicina (B Aires); 2007; 67(5):445-50. PubMed ID: 18051227
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
